RxDoctor Payments Data

Michael Nolen, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Little Rock, ARNPI 1164515318

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $11,129 of the $14,590 with a category attached, or 76.3%. It is spread thinly across 26 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $4,075 and has fallen 60.5% since, to $1,611 in 2025.

$14,590in general payments, 2019–2025

Across 204 payments — averaging $71.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Abiomed$3K
  • Atricure, Inc.$2K
  • Medtronic$1K
  • Edwards Lifesciences$799
  • Endologix LLC$414
  • plus $3K from 20 others
$6,210in research payments, 2019–2025

Across 4 payments — averaging $1552.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$6K

What the payments were for

  • Travel & lodging$3,46124%
  • Food & beverage$11,12976%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,590 in reported general payments places this provider in the 70th percentile of 48 thoracic surgery (cardiothoracic vascular surgery) providers in Arkansas.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Arkansas

Medicare billing

Part B allowed, 2024
$405,931
Medicare patients
266
Services billed
684

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$11,901
Atorvastatin Calcium14$220
Amlodipine Besylate14$121
Potassium Chloride16$115
Allopurinol188$112
Famotidine186$110
Metoprolol Tartrate34$98
Hydralazine Hcl14$62
Furosemide25$56
Hydrochlorothiazide14$22

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →